Why Is Krystal Biotech (KRYS) Down 11.5% Since Last Earnings Report?Zacks Investment Research • 03/19/26
Biotech Investor Adds $3 Million to Krystal Biotech as Revenue Hits $389 Million in 2025The Motley Fool • 02/22/26
Krystal Biotech Announces Fourth Quarter and Full Year 2025 Financial and Operating ResultsGlobeNewsWire • 02/17/26
Krystal Biotech to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026GlobeNewsWire • 02/10/26
Krystal Biotech (KRYS) is on the Move, Here's Why the Trend Could be SustainableZacks Investment Research • 01/26/26
Are You Looking for a Top Momentum Pick? Why Krystal Biotech, Inc. (KRYS) is a Great ChoiceZacks Investment Research • 01/23/26
KRYS Reports Preliminary Results for 2025, Outlines 2026 ObjectivesZacks Investment Research • 01/12/26
Krystal Biotech, Inc. (KRYS) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/12/26
Krystal Biotech Provides Business Update at 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/11/26
Recent Price Trend in Krystal Biotech (KRYS) is Your Friend, Here's WhyZacks Investment Research • 01/09/26
Krystal Biotech, Inc. (KRYS) Discusses Positive Interim Results and Next Steps for Cystic Fibrosis Program KB407 TranscriptSeeking Alpha • 01/09/26